ReviewMarine drugs2022
Deep-Sea Natural Products from Extreme Environments: Cold Seeps and Hydrothermal Vents.
Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 32 citations in OpenAlex.
- New Cytotoxic Anthraquinone Derivatives from a Deep-Sea-DerivedMarine drugs · 2026Article
- Multi-Omic Assessment of Microbial Communities and Their Polyketide Biosynthetic Potential Across Abyssal Sediments.Environmental microbiology · 2026Article
- Chrysogenones A-E: Malonyl-Modified Ergosterone Derivatives from Deep-Sea-DerivedMarine drugs · 2026Article
- Discovery of Antimicrobial Oligoindoles from a Cold-Seep-DerivedMarine drugs · 2025Article
- Exploring the Biosynthetic Potential of Microorganisms from the South China Sea Cold Seep Using Culture-Dependent and Culture-Independent Approaches.Marine drugs · 2025Article
- The thiodiketopiperazine derivatives shovelmycin A-B and ansamycin derivative divergolide X from the cold-seep-derived Streptomyces olivaceus HDN22-001.The Journal of antibiotics · 2025Article
- Structurally Diverse New Metabolites from Three Hadal Trench-Derived Microorganisms.ACS omega · 2025Article
- Statins Diversity Revealed by the Deep-Sea-Derived FungusMarine drugs · 2025Article
- GC/MS Fatty Acid Profile of Marine-Derived Actinomycetes from Extreme Environments: Chemotaxonomic Insights and Biotechnological Potential.Marine drugs · 2024Article
- Anthoteibinenes A-E from the Irish Deep-Sea CoralOrganic letters · 2024Article
- Going to extremes: progress in exploring new environments for novel antibiotics.npj antimicrobials and resistance · 2024Review
- New Phenol Derivatives from the Haima Cold Seep-Derived FungusMarine drugs · 2024Article
- Pseudallenes A and B, new sulfur-containing ovalicin sesquiterpenoid derivatives with antimicrobial activity from the deep-sea cold seep sediment-derived fungusBeilstein journal of organic chemistry · 2024Article
- A comprehensive genomic catalog from global cold seeps.Scientific data · 2023Article
- The Phylogeny, Metabolic Potentials, and Environmental Adaptation of an Anaerobe,Microorganisms · 2023Article
- The Cytotoxic Properties of Extreme Fungi's Bioactive Components-An Updated Metabolic and Omics Overview.Life (Basel, Switzerland) · 2023Review
- Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance.Marine drugs · 2023Review
- Ecotoxicological Assessment of Heavy Metal and Its Biochemical Effect in Fishes.BioMed research international · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
The deep sea has been proven to be a great treasure for structurally unique and biologically active natural products in the last two decades. Cold seeps and hydrothermal vents, as typical representatives of deep-sea extreme environments, have attracted more and more attention. This review mainly summarizes the natural products of marine animals, marine fungi, and marine bacteria derived from deep-sea cold seeps and hydrothermal vents as well as their biological activities. In general, there were 182 compounds reported, citing 132 references and covering the literature from the first report in 1984 up to March 2022. The sources of the compounds are represented by the genera
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.